We demonstrated that C21orf58 displayed oncogenic role in promoting cell growth, tumorigenesis and sorafenib resistance of HCC cells by abnormal activation of STAT3 signaling. This evidence concerns the gene C21orf58 and hepatocellular carcinoma.